pubmed-article:20546237 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20546237 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
pubmed-article:20546237 | lifeskim:mentions | umls-concept:C0017601 | lld:lifeskim |
pubmed-article:20546237 | lifeskim:mentions | umls-concept:C0033085 | lld:lifeskim |
pubmed-article:20546237 | lifeskim:mentions | umls-concept:C0033554 | lld:lifeskim |
pubmed-article:20546237 | lifeskim:mentions | umls-concept:C0332237 | lld:lifeskim |
pubmed-article:20546237 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
pubmed-article:20546237 | lifeskim:mentions | umls-concept:C1522168 | lld:lifeskim |
pubmed-article:20546237 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:20546237 | pubmed:dateCreated | 2010-6-15 | lld:pubmed |
pubmed-article:20546237 | pubmed:abstractText | The purpose of this study was to investigate the tolerability and intraocular pressure (IOP) reducing effect of the first preservative-free prostaglandin tafluprost (Taflotan) in patients exhibiting ocular surface side-effects during latanoprost (Xalatan) treatment. | lld:pubmed |
pubmed-article:20546237 | pubmed:language | eng | lld:pubmed |
pubmed-article:20546237 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546237 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20546237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546237 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20546237 | pubmed:month | May | lld:pubmed |
pubmed-article:20546237 | pubmed:issn | 1755-3768 | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:Brignole-Baud... | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:PfeifferNorbe... | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:RiedelTobiasT | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:UusitaloHannu... | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:PuskaPäiviP | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:KaarnirantaKa... | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:ChenEnpingE | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:WinterMartinM | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:RopoAuliA | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:HofmannGünter... | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:HamacherThoma... | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:RichterUlrich... | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:LeinoMarkkuM | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:PalmgrenElina... | lld:pubmed |
pubmed-article:20546237 | pubmed:author | pubmed-author:PetzoldGernot... | lld:pubmed |
pubmed-article:20546237 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20546237 | pubmed:volume | 88 | lld:pubmed |
pubmed-article:20546237 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20546237 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20546237 | pubmed:pagination | 329-36 | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:meshHeading | pubmed-meshheading:20546237... | lld:pubmed |
pubmed-article:20546237 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20546237 | pubmed:articleTitle | Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication. | lld:pubmed |
pubmed-article:20546237 | pubmed:affiliation | University of Tampere and Tampere University Hospital, Finland. hannu.uusitalo@uta.fi <hannu.uusitalo@uta.fi> | lld:pubmed |
pubmed-article:20546237 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20546237 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:20546237 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20546237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20546237 | lld:pubmed |